Pharmacological properties of tofenacine hydrochloride: N-methyl-2-[(o-methyl-a-phenylbenzyl)oxy]ethylamine hydrochloride.
D000759:Adjuvants, Anesthesia; D000317:Adrenergic alpha-Antagonists; D000818:Animals; D000927:Anticonvulsants; D001794:Blood Pressure / Q000187:drug effects; D001831:Body Temperature / Q000187:drug effects; D002490:Central Nervous System / Q000187:drug effects; D003331:Coronary Vessels / Q000187:drug effects; D004232:Diuretics; D004357:Drug Synergism; D005021:Ethylamines / Q000494:pharmacology* / Q000633:toxicity; D005260:Female; D006168:Guinea Pigs; D006591:Hexobarbital / Q000494:pharmacology; D006634:Histamine H1 Antagonists; D008124:Locomotion / Q000187:drug effects; D008297:Male; D051379:Mice; D009043:Motor Activity / Q000187:drug effects; D009538:Nicotine / Q000037:antagonists & inhibitors; D009638:Norepinephrine / Q000494:pharmacology; D009966:Orphenadrine / Q000494:pharmacology / Q000633:toxicity; D010276:Parasympatholytics; D011680:Pupil / Q000187:drug effects; D051381:Rats; D012119:Respiration / Q000187:drug effects; D012472:Salivation / Q000187:drug effects; D013747:Tetrabenazine / Q000037:antagonists & inhibitors; D014203:Tremorine / Q000037:antagonists & inhibitors
D000759:Adjuvants, Anesthesia; D000317:Adrenergic alpha-Antagonists; D000927:Anticonvulsants; D004232:Diuretics; D005021:Ethylamines; D006634:Histamine H1 Antagonists; D010276:Parasympatholytics; D009538:Nicotine; D009966:Orphenadrine; D006591:Hexobarbital; D014203:Tremorine; D009638:Norepinephrine; D013747:Tetrabenazine